The reported statements, read against the company's own industry.
Financials view
Market Capitalization
941.05MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Trailing P/E
70.06x
vs Medical Devices peers
Updated Oct 27, 2026
Revenue (TTM)
1.66BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Profit Margin
0.78%
vs Medical Devices peers
Updated Oct 27, 2026
Beta
1.21x
vs all stocks
Updated Oct 27, 2026
52-Week Change
-23.97%
vs all stocks
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Market Capitalization
941.05MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Enterprise Value
2.62BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Trailing P/E
70.06x
vs Medical Devices peers
Updated Oct 27, 2026
Forward P/E
4.99x
vs Medical Devices peers
Updated Oct 27, 2026
PEG Ratio
-0.6941x
vs Medical Devices peers
Updated Oct 27, 2026
Price to Sales (TTM)
0.5591x
vs Medical Devices peers
Updated Oct 27, 2026
Price to Book (MRQ)
0.8688x
vs Medical Devices peers
Updated Oct 27, 2026
Enterprise to Revenue
1.58x
vs Medical Devices peers
Updated Oct 27, 2026
Enterprise to EBITDA
7.85x
vs Medical Devices peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 10.68×.Updated Oct 27, 2026
Gross Margin
52.47%
vs Medical Devices peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 56.46%.Updated Oct 27, 2026
Profit Margin
0.78%
vs Medical Devices peers
Updated Oct 27, 2026
Operating Margin
6.33%
vs Medical Devices peers
Updated Oct 27, 2026
Return on Assets (TTM)
3.13%
vs Medical Devices peers
Updated Oct 27, 2026
Return on Equity (TTM)
1.24%
vs Medical Devices peers
Updated Oct 27, 2026
Revenue (TTM)
1.66BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue per Share (TTM)
21.49USDUpdated Oct 27, 2026
Quarterly Revenue Growth
2.30%
vs Medical Devices peers
Updated Oct 27, 2026
Gross Profit (TTM)
935.44MUSD
vs all stocks (USD)
Updated Oct 27, 2026
EBITDA (TTM)
245.19MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Net Income (TTM)
13.01MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Quarterly Earnings Growth (YoY)
0.76%
vs Medical Devices peers
Updated Oct 27, 2026
Operating Cash Flow (TTM)
140.40MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Levered Free Cash Flow (TTM)
116.03MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Payout Ratio
0.00%
vs Medical Devices peers
Updated Oct 27, 2026
Revenue
1.64BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
803.63MUSDFY2025 · Dec 31, 2025
Gross Profit
831.62MUSDFY2025 · Dec 31, 2025
Operating Income
18.00MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-563.50MUSDFY2025 · Dec 31, 2025
Income Tax Expense
-47.03MUSDFY2025 · Dec 31, 2025
Net Income
-516.47MUSDFY2025 · Dec 31, 2025
EBIT
-477.25MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
185.95MUSDFY2025 · Dec 31, 2025
Research & Development
98.97MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
699.70MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
18.47MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
86.25MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-6.74USDFY2025 · Dec 31, 2025
EPS (Diluted)
-6.74USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
76.67MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
76.67MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-516.47MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-458.67MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-540.11MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
235.05MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-516.47MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
151.83MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-66.26MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
18.58MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
-15.41MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-485.00KUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
26.72MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-57.17MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-81.44MUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
-14.20MUSDFY2025 · Dec 31, 2025
Net Acquisitions
0.00USDFY2025 · Dec 31, 2025
Purchase of Investments
-19.43MUSDFY2025 · Dec 31, 2025
Sale of Investments
7.00MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-93.86MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
720.70MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-669.89MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-221.00KUSDFY2025 · Dec 31, 2025
Other Financing Charges
-23.21MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
27.38MUSDFY2025 · Dec 31, 2025
Shares Outstanding
77.78MSharesUpdated Oct 27, 2026
Float Shares
58.63MSharesUpdated Oct 27, 2026
Shares Short
7.27MSharesUpdated Oct 27, 2026
Short Ratio
8.11days
vs all stocks
Updated Oct 27, 2026
Short % of Shares Outstanding
12.88%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 9.34%.Updated Oct 27, 2026
% Held by Insiders
14.39%
vs all stocks
Updated Oct 27, 2026
% Held by Institutions
98.65%
vs all stocks
Updated Oct 27, 2026
Total Cash (MRQ)
311.93MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Cash per Share (MRQ)
4.01USDUpdated Oct 27, 2026
Total Debt (MRQ)
2.00BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Debt to Equity (MRQ)
1.88x
vs Medical Devices peers
Updated Oct 27, 2026
Current Ratio (MRQ)
3.62x
vs Medical Devices peers
Updated Oct 27, 2026
Book Value per Share (MRQ)
13.71USDUpdated Oct 27, 2026
Total Assets
3.60BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.16BUSDFY2025 · Dec 31, 2025
Total Liabilities
2.56BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
2.44BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.10BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
455.98MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
235.05MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
28.69MUSDFY2025 · Dec 31, 2025
Accounts Receivable
278.85MUSDFY2025 · Dec 31, 2025
Inventory
492.74MUSDFY2025 · Dec 31, 2025
Accounts Payable
95.73MUSDFY2025 · Dec 31, 2025
Short-term Debt
140.57MUSDFY2025 · Dec 31, 2025
Deferred Revenue
11.46MUSDFY2025 · Dec 31, 2025
Long-term Debt
1.89BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
204.28MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
923.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
423.44MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.04BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
689.21MUSDFY2025 · Dec 31, 2025
52-Week Low
8.70USDUpdated Oct 27, 2026
52-Week High
20.49USDUpdated Oct 27, 2026
52-Week Change
-23.97%
vs all stocks
Updated Oct 27, 2026
Beta
1.21x
vs all stocks
Updated Oct 27, 2026
50-Day MA
15.34USDUpdated Oct 27, 2026
200-Day MA
14.08USDUpdated Oct 27, 2026
Avg 10-Day Volume
1.16MSharesUpdated Oct 27, 2026
Avg 30-Day Volume
1.18MSharesUpdated Oct 27, 2026
Diluted EPS (TTM)
0.1700USDUpdated Oct 27, 2026
Other Income / Expense
-513.72MUSDFY2025 · Dec 31, 2025
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 1.88×, higher than 95% of its Medical Devices peers (median 0.11×)Significant